![]() |
|
#1
|
|||
|
|||
|
(Reuters) - GlaxoSmithKline Plc said on Saturday its asthma drug, Nucala, which is already approved in the United States and Europe, showed a similar safety profile in a long-term study compared with previous studies. ![]() ??????? ??????: GSK asthma drug Nucala?s long-term study supports safety profile || ??????: ahlam1399 || ??????: اسم منتداك
|
![]() |
|
|